Evidence map›Paper›PMID 38688660›Full record

ArticleThe British journal of radiology2024

CT-based radiomics model using stability selection for predicting the World Health Organization/International Society of Urological Pathology grade of clear cell renal cell carcinoma.

Haijie Zhang, Fu Yin, Menglin Chen, Anqi Qi, Liyang Yang, Ge Wen

Abstract read
In one paragraph

Article in The British journal of radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Haijie ZhangNuclear Medicine Department, Center of PET/CT, Shenzhen Second People's Hospital, Shenzhen 518052, China.
Fu YinSchool of Electronic and Communication Engineering, Shenzhen Polytechnic University, Shenzhen 518052, China.
Menglin ChenMedical Imaging Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Anqi QiMedical Imaging Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Liyang YangMedical Imaging Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Ge WenMedical Imaging Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.ORCID 0000-0003-2114-9157

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to develop a model to predict World Health Organization/International Society of Urological Pathology (WHO/ISUP) low-grade or high-grade clear cell renal cell carcinoma (ccRCC) using 3D multiphase enhanced CT radiomics features (RFs).

methodsCT data of 138 low-grade and 60 high-grade ccRCC cases were included. RFs were extracted from four CT phases: non-contrast phase (NCP), corticomedullary phase, nephrographic phase, and excretory phase (EP). Models were developed using various combinations of RFs and subjected to cross-validation.

resultsThere were 107 RFs extracted from each phase of the CT images. The NCP-EP model had the best overall predictive value (AUC = 0.78), but did not significantly differ from that of the NCP model (AUC = 0.76). By considering the predictive ability of the model, the level of radiation exposure, and model simplicity, the overall best model was the Conventional image and clinical features (CICFs)-NCP model (AUC = 0.77; sensitivity 0.75, specificity 0.69, positive predictive value 0.85, negative predictive value 0.54, accuracy 0.73). The second-best model was the NCP model (AUC = 0.76).

conclusionsCombining clinical features with unenhanced CT images of the kidneys seems to be optimal for prediction of WHO/ISUP grade of ccRCC. This noninvasive method may assist in guiding more accurate treatment decisions for ccRCC. ADVANCES IN KNOWLEDGE: This study innovatively employed stability selection for RFs, enhancing model reliability. The CICFs-NCP model's simplicity and efficacy mark a significant advancement, offering a practical tool for clinical decision-making in ccRCC management.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsNeoplasm GradingTomography, X-Ray ComputedAdultAgedAged, 80 and overFemaleHumansImaging, Three-DimensionalMaleMiddle AgedPredictive Value of TestsRadiomicsRetrospective StudiesSensitivity and Specificityclear cell renal carcinomaradiomicsstability selectiontreatment decisionstumour grade

Identifiers

PMID38688660
PMCPMC11135802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.